in reference to your comments yes I agree this company can still be vey viable with the right deals being made . As for saying I have been slagging on the management , some here just don’t give up throwing negative comments . I was just stating the obvious on how the company arrived at where it is A new investor with half a brain can see the issues caused by bad management with this company and I would suggest only those smart enough to see the entrinsic value in the company are prepared to take the punt on investing and let’s face it , it is a punt . Like I said I made a substantial amount on AHZ before and I was going to reinvest a few years ago but it just did not stack up for me at the time . Usually with Biotecs I like to see enough capital to fund themselves for 12 mths or more . Letting the company funds get to the point where there is only 6 mths or less is a bad position to do a CR from especialy if it’s not supported as well as expected . I totally understand where your comming from about those who have bought in at $1.80 really even those who have bought in at 40c I feel really sorry for them but sometimes that’s the nature of the beast with biotecs . What’s disappointing here is we have great products nearly to market and little funds . That’s not usually how biotecs fail it usually the product does not perform as expected , I still see potential for this company to get back on its feet , And yes would have been a huge boost had a deal been cut and announced the sametime as the CE approval but hey it might be just around the corner
- Forums
- ASX - By Stock
- AVR
- News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval
News: AHZ Admedus Says Cardiocel 3D And Vascucel Receives European Regulatory Approval, page-155
-
- There are more pages in this discussion • 413 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$11.30 |
Change
-0.650(5.44%) |
Mkt cap ! $238.8M |
Open | High | Low | Value | Volume |
$11.71 | $11.83 | $11.24 | $346.8K | 29.94K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 90 | $11.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$11.50 | 50 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 90 | 11.050 |
2 | 228 | 11.000 |
1 | 25 | 10.990 |
1 | 500 | 10.960 |
1 | 1000 | 10.820 |
Price($) | Vol. | No. |
---|---|---|
11.500 | 50 | 1 |
11.800 | 200 | 1 |
12.000 | 5023 | 2 |
12.010 | 191 | 1 |
12.020 | 1000 | 1 |
Last trade - 16.10pm 28/10/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |